Table 2. Pre- and post-intervention physical performance measurements in each group.
Variables Group Pre-Test Post-Test ES+[95%Cl] Δ% Main and Interaction Effects Post-hoc pairwise comparisons
Between-group p ES+[95%Cl]
BS-1RM LL-CT
ML-CT
CON		 127.1±5.9
123.6±3.4
123.5±3.2		 133.5±4.1**#
135.5±2.6**#
126.7±3.3**		 1.49[1.08,1.90]
2.66[2.26,3.07]
0.73[0.30,1.16]		 5.4%
9.8%
2.7%		 Time:p<0.001
Group:p=0.007
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.010
0.032
1.000		 0.75[0.16,1.35]
1.93[1.34,2.52]
1.18[0.60,1.75]
BP-1RM LL-CT
ML-CT
CON		 70.2 ±5.3
68.9±4.9
66.8±5.0		 76.5±5.0**#
78.3±5.8**#
68.1±4.3		 1.24[0.87,1.60]
1.82[1.46,2.18]
0.31[-0.07,0.69]		 9.4%
13.9%
2.7%		 Time:p<0.001
Group:p=0.010
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.026
0.020
1.000		 0.93[0.40,1.46]
1.51[0.98,2.04]
0.58[0.07,1.10]
CMJ LL-CT
ML-CT
CON		 61.7±4.9
61.2±4.3
57.4±4.5		 65.7±5.4**#
67.0±4.1**#
58.6±4.3		 0.91[0.70,1.12]
1.23[1.02,1.44]
0.19[[-0.03,0.41]		 7.0%
9.6%
1.6%		 Time:p<0.001
Group:p=0.005
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.013
0.011
1.000		 0.72[0.42,1.03]
1.04[0.74,1.35]
0.32[0.03,0.62]
SJ LL-CT
ML-CT
CON		 50.3±4.2
49.6±3.0
47.7±3.9		 53.9±4.2**#
54.4±2.9**#
47.4±4.5		 0.89[0.58,1.20]
1.30[0.99,1.61]
-0.01[-0.04,0.32]		 6.7%
10.2%
0.02%		 Time:p<0.001
Group:p=0.012
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.027
0.026
1.000		 0.90[0.45,1.35]
1.31[0.86,1.77]
0.41[-0.03,0.86]
30M LL-CT
ML-CT
CON		 4.32±0.07
4.32±0.06
4.36±0.10		 4.24±0.08**
4.19±0.07**#
4.34±0.12		 1.02[0.39,1.64]
1.76[1.13,2.38]
-0.20[-0.87,0.45]		 -1.9%
-3.2%
-0.3%		 Time:p<0.001
Group:p=0.022
Interaction:p=0.007		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.103
0.026
1.000		 1.22[0.31,2.13]
1.96[1.05,2.87]
0.74[-0.13,1.61]
505 LL-CT
ML-CT
CON		 2.31±0.10
2.33±0.08
2.38±0.04		 2.24±0.11**#
2.24±0.11**#
2.38±0.06		 0.92[0.47,1.38]
1.22[0.76,1.67]
0.12[-0.36,0.60]		 -3.3%
-4.3%
-0.5%		 Time:p<0.001
Group:p=0.010
Interaction:p=0.006		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.015
0.047
1.000		 0.80[0.12,1.46]
1.09[0.43,1.76]
0.30[-0.35,0.95]
VO2max LL-CT
ML-CT
CON		 51.2±3.0
50.9±2.5
49.2±2.2		 53.9±2.8**##
52.7±2.1**#
48.5±2.3		 1.02[0.64,1.40]
0.65[-.27,1.03]
0.23[-0.17,0.63]		 5.4%
3.5%
-1.2%		 Time:p<0.001
Group:p=0.003
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.003
0.028
1.000		 0.80[0.24,1.35]
0.42[-0.13,0.97]
-0.37[-0.91,0.16]
PP (W) LL-CT
ML-CT
CON		 761.5±37.3
767.3±51.9
735.7±28.5		 794.4±39.8**#
832.0±45.3**##
723.6±47.7		 0.82[0.33,1.31]
1.54[1.04,2.03]
-0.26[-0.78,0.26]		 4.6%
8.5%
-1.5%		 Time:p<0.001
Group:p<0.001
Interaction:p<0.001		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 0.018
0.001
0.544		 1.08[0.37,1.80]
1.80[1.08,2.52]
0.72[0.02,1.42]
RPP LL-CT
ML-CT
CON		 10.5±0.6
10.5±0.9
10.4±0.4		 10.8±0.7**
10.9±0.9**
10.5±0.4		 0.50[0.22,0.79]
0.68[0.40,0.97]
0.30[0.00,0.60]		 3.4%
4.7%
2.1%		 Time:p<0.001
Group:p=0.763
Interaction:p=0.188		 LL-CT vs CON
ML-CT vs CON
ML-CT vs LL-CT		 1.000
1.000
1.000		 0.20[-0.21,0.62]
0.38[-0.03,0.80]
018[-0.22,0.58]
BS-1RM: Squat One-Repetition Maximum; BP-1RM: Bench Press One-Repetition Maximum; CMJ: Countermovement Jump; SJ: Squat Jump; 505: 505 Change-of-Direction Test; 30M: 30-Meter Sprint; VO2max: Maximal Oxygen Uptake; PP: Peak Anaerobic Power; PP/kg: Relative Peak Anaerobic Power;Δ%: Individual responsiveness (% change from pre- to post-intervention);* indicates a significant within-group difference, p < 0.05;** indicates a highly significant within-group difference, p < 0.01;# indicates a significant between-group difference compared to the control group, p < 0.05;## indicates a highly significant between-group difference compared to the control group, p < 0.01.